30 related articles for article (PubMed ID: 7053304)
1. The Role of Metabolites of Antidepressants in the Treatment of Depression.
Rudorfer MV; Potter WZ
CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of tricyclic antidepressants.
Rudorfer MV; Potter WZ
Cell Mol Neurobiol; 1999 Jun; 19(3):373-409. PubMed ID: 10319193
[TBL] [Abstract][Full Text] [Related]
3. Monitoring tricyclic antidepressant therapy.
Rudorfer MV
Pharmacoeconomics; 1992 Feb; 1(2):148-50. PubMed ID: 10147108
[No Abstract] [Full Text] [Related]
4. Drug-induced orthostatic hypotension in the elderly: avoiding its onset.
Verhaeverbeke I; Mets T
Drug Saf; 1997 Aug; 17(2):105-18. PubMed ID: 9285201
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic optimisation of tricyclic antidepressant therapy.
Furlanut M; Benetello P; Spina E
Clin Pharmacokinet; 1993 Apr; 24(4):301-18. PubMed ID: 8491058
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.
von Moltke LL; Greenblatt DJ; Shader RI
Clin Pharmacokinet; 1993 Feb; 24(2):141-60. PubMed ID: 8471078
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced orthostatic hypotension in older patients.
Mets TF
Drugs Aging; 1995 Mar; 6(3):219-28. PubMed ID: 7620234
[TBL] [Abstract][Full Text] [Related]
8. Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
Rudorfer MV; Lane EA; Chang WH; Zhang MD; Potter WZ
Br J Clin Pharmacol; 1984 Apr; 17(4):433-40. PubMed ID: 6721989
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetic considerations in the elderly. An update.
Dawling S; Crome P
Clin Pharmacokinet; 1989 Oct; 17(4):236-63. PubMed ID: 2686883
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of antidepressants in the elderly.
Nolan L; O'Malley K
Drugs Aging; 1992; 2(5):450-8. PubMed ID: 1392225
[TBL] [Abstract][Full Text] [Related]
11. Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine.
Pollock BG; Perel JM
Psychopharmacology (Berl); 1992; 109(1-2):57-62. PubMed ID: 1365672
[TBL] [Abstract][Full Text] [Related]
12. Active metabolites of imipramine and desipramine in man.
Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
[TBL] [Abstract][Full Text] [Related]
13. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
[TBL] [Abstract][Full Text] [Related]
14. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
Spina E; Arena A; Pisani F
Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of imipramine and desipramine.
Sallee FR; Pollock BG
Clin Pharmacokinet; 1990 May; 18(5):346-64. PubMed ID: 2185906
[TBL] [Abstract][Full Text] [Related]
16. Use of desipramine in depressed inpatients.
Nelson JC
J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):10-6. PubMed ID: 6384205
[TBL] [Abstract][Full Text] [Related]
17. Altered hydroxydesipramine concentrations in elderly depressed patients.
Kitanaka I; Ross RJ; Cutler NR; Zavadil AP; Potter WZ
Clin Pharmacol Ther; 1982 Jan; 31(1):51-5. PubMed ID: 7053304
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
